| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |